Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows

• Main Authors: Maria Chianese (Author), Gianluca Screm (Author), Francesco Salton (Author), Paola Confalonieri (Author), Liliana Trotta (Author), Mariangela Barbieri (Author), Luca Ruggero (Author), Marco Mari (Author), Nicolò Reccardini (Author), Pietro Geri (Author), Michael Hughes (Author), Selene Lerda (Author), Marco Confalonieri (Author), Lucrezia Mondini (Author), Barbara Ruaro (Author)
• Format: Book
• Published: MDPI AG, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pirfenidone and Nintedanib are specific drugs used against idiopathic pulmonary fibrosis (IPF) that showed efficacy in non-IPF fibrosing interstitial lung diseases (ILD). Both drugs have side effects that affect patients in different ways and have different levels of severity, making treatment even...